Protalix BioTherapeutics, Inc. Annual Depreciation in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2012 to 2023.
  • Protalix BioTherapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $322K, a 15% increase year-over-year.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2023 was $1.19M, a 9.67% increase from 2022.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2022 was $1.09M, a 2.86% decline from 2021.
  • Protalix BioTherapeutics, Inc. annual Depreciation for 2021 was $1.12M, a 14.1% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.19M +$105K +9.67% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $1.09M -$32K -2.86% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $1.12M -$184K -14.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $1.3M -$315K -19.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $1.62M -$54K -3.23% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 $1.67M -$249K -13% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-30
2017 $1.92M -$63K -3.18% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $1.98M -$387K -16.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $2.37M -$770K -24.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-06
2014 $3.14M -$399K -11.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $3.54M -$153K -4.14% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 $3.69M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.